EGFR and non-small cell lung carcinoma: Importantly, this is the first study, to the best of our knowledge, investigating the ability of radiomics-based models to predict acquired EGFR T790M mutation in Chinese patients with advanced NSCLC bearing an EGFR-activating mutation by utilizing CT imaging from treatment-naïve patients with NSCLC.